Skip to content

Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)

Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1) - Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048902
Enrollment
963
Registered
2022-09-10
Start date
2022-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Sponsors

Japan Clinical Oncology Group (JCOG)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Total 963 patients registered for the JCOG0707: "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non- small cell lung cancer"

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Overall survival

Secondary

MeasureTime frame
Recurrence-free survival, site of recurrence, cumulative incidence of secondary cancer, cumulative incidence of death from primary lung cancer, cumulative incidence of all causes of deaths (deaths from cancers and deaths from non-cancer causes)

Countries

Japan

Contacts

Public ContactMasaya Yotsukura

JCOG0707A1 Coordinating Office National Cancer Center Hospital, Department of Thoracic Surgery

mayotsuk@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026